Evidence map›Paper›PMID 33124494›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2021

Expanding Access to COVID-19 Tests through US Postal Service Facilities.

Bismark Singh, Simon Risanger, David Morton, Michael Pignone, Lauren Ancel Meyers

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Differential diagnosis of COVID-19 and influenza.PLOS global public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bismark SinghDepartment of Mathematics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-6943-657X
Simon RisangerDepartment of Industrial Economics and Technology Management, Norwegian University of Science and Technology, Trondheim, Norway.
David MortonDepartment of Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL, USA.
Michael PignoneDepartment of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Lauren Ancel MeyersDepartment of Integrative Biology and Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, TX, USA.ORCID 0000-0002-5828-8874

Funding

Accelerating viral outbreak detection in US cities using mechanistic models, machine learning and diverse geospatial dataR01AI151176 · NIAID · YALE UNIVERSITY · PI GALVANI, ALISON P, MEYERS, LAUREN ANCEL · 2020 to 2024
$3.9M
RFA-IP-22-004, Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenzaU01IP001136 · IP · UNIVERSITY OF TEXAS AT AUSTIN · PI MEYERS, LAUREN ANCEL · 2020 to 2024
$3.4M
NCIRD CDC HHS U01 IP001136NIAID NIH HHS R01 AI151176
6 · The paper itself

Abstract

Widespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative evidence that even a subset of USPS facilities could provide broad access, particularly in remote and at-risk communities with limited access to health care. Based on daily travel surveys, census data, locations of USPS facilities, and an established care-seeking model, we estimate that more than 94% of the US population would be willing to travel to an existing USPS facility if warranted. For half of the US population, this would require traveling less than 2.5 miles from home; for 90%, the distance would be less than 7 miles. In Georgia, Illinois, and Minnesota, we estimate that testing at USPS facilities would provide access to an additional 4.1, 3.1, and 1.3 million people and reduce the median travel distance by 3.0, 0.8, and 1.2 miles, respectively, compared with existing testing sites per 28 July 2020. We also discuss the option of distributing test-at-home kits via USPS instead of private carriers. Finally, our proposal provides USPS an opportunity to increase revenues and expand its mission, thus improving its future prospects and relevance.

Indexed as

COVID-19 TestingCOVID-19Health Services AccessibilityHumansPostal ServiceRural PopulationSARS-CoV-2United StatesCOVID-19optimizationtestingunderserved populationsUSPS

Identifiers

PMID33124494
PMCPMC7780264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.